These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 2102134)

  • 21. Improved antihypertensive efficacy of the felodipine-metoprolol extended-release tablet compared with each drug alone.
    Dahlöf B; Jönsson L; Borgholst O; Ekblad G; Engstrand C; Grundestam I; Lindh A
    Blood Press Suppl; 1993; 1():37-45. PubMed ID: 8173689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ketanserin in mild to moderate hypertension in the elderly: a double-blind study versus methyldopa.
    Cattin L; Da Col PG
    Clin Ther; 1989; 11(3):363-72. PubMed ID: 2663164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Local hemodynamic effects of serotonin and ketanserin in healthy subjects: studies in the forearm.
    Blauw GJ; van Brummelen P; Bruning T; van Zwieten PA
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S41-3. PubMed ID: 2459513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of carvedilol and metoprolol on blood pressure, blood flow, and vascular resistance.
    Morgan T; Snowden R; Butcher L
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S124-9. PubMed ID: 2454358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Haemodynamic effects of an antihypertensive diuretic substance on the forearm circulation of patients with essential hypertension.
    Bouthier JA; Safar ME; Deschamps E; Tarrade T
    Drugs Exp Clin Res; 1988; 14(2-3):221-4. PubMed ID: 3416724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemodynamic and 24-h blood pressure profile of amlodipine monotherapy.
    Ibrahim MM; el-Boghdadly B; Zaghloul SS
    J Hum Hypertens; 1996 Jul; 10(7):489-94. PubMed ID: 8880565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment for one year with perindopril: effect on cardiac mass and arterial compliance in essential hypertension.
    Asmar RG; Journo HJ; Lacolley PJ; Santoni JP; Billaud E; Levy BI; Safar ME
    J Hypertens Suppl; 1988 Dec; 6(3):S33-9. PubMed ID: 3225688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence and clinical relevance of QT prolongation caused by the new selective serotonin antagonist ketanserin. Multicenter Ketanserin Research Group.
    Zehender M; Meinertz T; Hohnloser S; Geibel A; Hartung J; Seiler KU; Just H
    Clin Physiol Biochem; 1990; 8 Suppl 3():90-100. PubMed ID: 2132179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of hypertension associated with stable angina pectoris: favourable interaction between new metoprolol formulation (OROS) and nifedipine.
    Di Somma S; de Divitiis M; Bertocchi F; Carotenuto A; Cudemo G; Petitto M; Napodano M; de Divitiis O
    Cardiologia; 1996 Jul; 41(7):635-43. PubMed ID: 8831181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute haemodynamic effect of metoprolol in essential hypertension.
    Pechán J; Mikulecký M; Srbecký M
    Cor Vasa; 1988; 30(1):51-9. PubMed ID: 3132353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ketanserin in the treatment of essential hypertension. A double-blind study against metoprolol and a further long-term open treatment.
    Milei J; Lemus J; Bernardiner E
    Acta Cardiol; 1986; 41(6):427-41. PubMed ID: 3544622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of acute and chronic effects of ketanserin in the treatment of hypertension and hypothesis on a new mechanism of action].
    Sechi LA
    Ann Ital Med Int; 1990; 5(4 Pt 2):433-50. PubMed ID: 2102130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparative study of ketanserin and metoprolol in essential hypertension.
    Seedat YK; Parag KB
    S Afr Med J; 1985 Oct; 68(8):555-8. PubMed ID: 2931840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical aspects during therapy with the serotonin antagonist ketanserin.
    Distler A
    Clin Physiol Biochem; 1990; 8 Suppl 3():64-80. PubMed ID: 1983424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparison of the antihypertensive effects of bopindolol and metoprolol in the treatment of arterial hypertension].
    Bagatin J; Kuzmanić A; Rumboldt Z; Mirić D; Naranca M; Obad M; Pivac N; Polić S; Rakić D
    Med Pregl; 1990; 43(3-4):145-8. PubMed ID: 1978233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Humoral and hemodynamic (systemic and renal) effects of ketanserin in patients with essential hypertension: what is the role of prostaglandins?].
    Lucarini AR
    Ann Ital Med Int; 1990; 5(4 Pt 2):464-8. PubMed ID: 2102133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological modulation of stress-induced cardiovascular hyperreactivity in essential hypertension.
    Schulte W; Rüddel H; Schmieder R; Schächinger H; Bräutigam M; Welzel D
    J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S70-3. PubMed ID: 1376841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes induced by nicardipine slow release in forearm and myocardial hemodynamics of subjects with essential hypertension.
    Pancera P; Sheiban I; Ribul M; Priante F; De Marchi S; Zannoni M; Arosio E; Lechi A
    Panminerva Med; 1994 Mar; 36(1):25-9. PubMed ID: 8090539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Betablocking drugs in essential hypertension: transdermal bupranolol compared with oral metoprolol.
    Jeck T; Edmonds D; Mengden T; Schubert M; Renz I; Weisser B; Vetter W
    Int J Clin Pharmacol Res; 1992; 12(3):139-48. PubMed ID: 1473881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indenolol: a new antihypertensive agent: efficacy, toxicity, and hemodynamic effects in a crossover double-blind study with metoprolol.
    Trimarco B; Cuocolo A; Groothold G; Ricciardelli B; De Luca N; Volpe M; Veniero AM; Condorelli M
    J Clin Pharmacol; 1985; 25(5):328-36. PubMed ID: 4031109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.